Ignite Creation Date:
2025-12-25 @ 3:08 AM
Ignite Modification Date:
2026-02-28 @ 9:44 PM
Study NCT ID:
NCT04077905
Status:
UNKNOWN
Last Update Posted:
2019-09-06
First Post:
2019-08-31
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Pegylated Liposomal Doxorubicin as a Induction Therapy for Lymphoma Induced Hemophagocytic Lymphohistiocytosis.
Sponsor:
Beijing Friendship Hospital
Organization:
Organization Data
Organization:
Class:
OTHER
Study ID:
CSPC-DMS-HLH-01
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
OTHER
Responsible Party:
Responsible Party Title:
Responsible Party Type:
PRINCIPAL_INVESTIGATOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None